Denali Therapeutics Overview
Denali Therapeutics Target Price
Analysts' 12-month price predictions for DNLI.
Get informed when a big investor buys or sells
+ FollowShare Price
$24.77
Average Target Price
$32.80
32.4% upside
32.4% upside5 analysts in the last 4 months
High: $40 | Low: $23
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-22 | Morgan Stanley | $35 | 41.3% upside |  |
| 2026-05-22 | Deutsche Bank | $31 | 25.2% upside | |
| 2026-05-08 | WedbushLaura Chico | $23 |  7.1% downside | |
| 2026-03-26 | Deutsche Bank | $35 | 41.3% upside | |
| 2026-03-02 | JefferiesAndrew Tsai | $40 | 61.5% upside | |
| 2026-01-08 | Morgan StanleySean Laaman | $40 | 61.5% upside | |
| 2026-01-07 | UBSMichael Yee | $25 | 0.9% upside | |
| 2025-12-11 | WedbushLaura Chico | $30 | 21.1% upside | |
| 2025-12-05 | WedbushLaura Chico | $31 | 25.2% upside | |
| 2025-11-17 | Stifel NicolausPaul Mattels | $37 | 49.4% upside | |
| 2025-01-07 | BTIGThomas Shrader | $32 | 29.2% upside | |
| 2024-11-01 | JefferiesMichael Yee | $45 | 81.7% upside | |
| 2024-10-14 | BTIGThomas Shrader | $35 | 41.3% upside | |
| 2024-09-04 | Bank of America SecuritiesTazeen Ahmad | $29 | 17.1% upside | |
| 2024-09-03 | B.Riley FinancialMarank Mamtani | $33 | 33.2% upside | |
| 2024-09-03 | Goldman SachsSalveen Richter | $46 | 85.7% upside | |
| 2024-09-03 | Stifel NicolausPaul Mattels | $22 | 11.2% downside | |
| 2021-08-05 | Goldman SachsSalveen Richter | $112 | 352.2% upside | |
| 2021-05-18 | UBSEsther Rajavelu | $70 | 182.6% upside | |